Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Maedica|May 3, 2014
Indolent lymphoma: diagnosis and prognosis in medical practiceAnca Ciobanu, Oana Stanca, Irina Triantafyllidis, et al.Journal of Cellular and Molecular Medicine|November 6, 2002
Relationship between chromosomal changes complexity and disease aggressiveness in myeloid and lymphoid disordersAgripina Lungeanu, Aurora Arghir, Anca Lupu, et al.Pharmacy (Basel, Switzerland)|April 27, 2026
Knowledge, Attitudes, and Practices Regarding the Disposal of Unused and Expired Medicines in Romania During the Early Implementation of the 2023 Hospital-Based Collection FrameworkAnca Lupu, Ștefan Roșca, Ancuța Iacob, et al.Journal of Cellular and Molecular Medicine|August 9, 2002
Lymphoma immunophenotyping: "borderline" lymphomasDelia Mut-Popescu, Anca Lupu, H. Bumbea, et al.Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie|November 25, 2010
Prognostic and predictive significance of the bcl-2/IgH translocation in malignant follicular lymphomasAlina Georgescu, M Stoicea, Maria Comănescu, et al.Polymers|February 13, 2025
Assessment of the Effectiveness of Protective Coatings in Preventing Steel Corrosion in the Marine EnvironmentNicoleta Bogatu, Daniela Laura Buruiana, Alina Crina Muresan, et al.Frontiers in Oncology|September 26, 2019
LEAM vs. BEAM vs. CLV Conditioning Regimen for Autologous Stem Cell Transplantation in Malignant Lymphomas. Retrospective Comparison of Toxicity and Efficacy on 222 Patients in the First 100 Days After Transplant, On Behalf of the Romanian Society for Bone Marrow TransplantationAndrei Colita, Anca Colita, Horia Bumbea, et al.Romanian Journal of Anaesthesia and Intensive Care|November 2, 2017
Perioperative Patient Blood Management Programme. Multidisciplinary recommendations from the <i>Patient Blood Management Initiative Group</i>Daniela Filipescu, Răzvan Bănăţeanu, Mircea Beuran, et al.Maedica|May 4, 2017
2016 WHO Clinical Molecular and Pathological Criteria for Classification and Staging of Myeloproliferative Neoplasms (MPN) Caused by MPN Driver Mutations in the JAK2, MPL and CALR Genes in the Context of New 2016 WHO Classification: Prognostic and Therapeutic ImplicationsJan Jacques Michiels, Mihaela Tevet, Adrian Trifa, et al.Pageof 1